JNJ-1900

Paris, France and Cambridge, Massachusetts, USA, May 22, 2026 Nanobiotix, a late-stage clinical biotechnology company specializing in physics-based cancer...

PARIS, France and CAMBRIDGE, Mass., United States – May 4, 2026 Nanobiotix has announced FDA acceptance of a protocol...